redalpine

💥 The frontiers of gene therapy are expanding 💥 Congratulations to ExpressionEdits on their new collaboration with Boehringer Ingelheim to advance gene therapy through AI-powered intron optimization! Gene therapies often face limitations due to low therapeutic protein expression, requiring high viral loads or repeat dosing. ExpressionEdits’ Genetic Syntax Engine is tackling this challenge directly using its intronization technology, enhancing gene expression without altering the underlying genetic sequence. 💡 Why this matters: This collaboration unlocks new possibilities for gene therapy by enhancing protein expression at lower doses, improving efficacy while reducing risks. By using AI to refine the genome’s language, it enables more precise and accurate protein production, paving the way for more effective treatments. 🚀 #empoweringGameChangers: Michael and Philip continue to support the entire team around Kärt Tomberg, Liliana Antunes, Rebecca Godfrey, and Allan Bradley in their aim to bring better therapies to market faster. Read more here: https://lnkd.in/eYkSkkQm

The Times ranks LEGALFLY as leading AI innovator! ⚡️ We’re delighted to share that LegalFly has been featured in The Times’ list of 10 transformative AI innovations! LEGALFLY is redefining how legal teams manage contracts, compliance, and policy enforcement. By automating time-consuming tasks and ensuring airtight compliance, it helps organizations shorten deal cycles, increase accuracy, and stay ahead of evolving regulations. This recognition underscores the impact of LegalFly’s AI and the team’s dedication to innovation. Huge congratulations to Ruben Miessen and the entire LegalFly team on this milestone! 🎉 #empoweringGameChangers – We’re proud to support LegalFly’s journey, with Sebastian and Gianmarco actively working alongside the team to drive even greater success in 2025. 👉 Read more in The Times: https://lnkd.in/gNqGKRAp #VentureCapital #LegalTech #AI #Compliance #redalpine

👋 In case you missed it: our January newsletter is out!   🚀 #empoweringGameChangers - We kicked off 2025 with exciting news from Araris Biotech AG, Genialis, and 9fin, key promotions on our team, event highlights, and much more. Read the entire newsletter here: https://lnkd.in/efChwfkq If you enjoyed this newsletter, feel free to sign up to our mailing list: https://lnkd.in/dX6XcMwd

🚀 We’re excited to celebrate the well-deserved promotions of the following team members, whose dedication and contributions help drive the success of redalpine and our portfolio companies. • Marc Moesser & Gianmarco Hodel – both promoted to Investment Manager • Pascal Münch – promoted to Senior Finance Associate A huge congratulations to Marc, Gianmarco, and Pascal! Your hard work and commitment continue to fuel our mission of #empoweringGameChangers to help shape a better world 🎉

💥 Europe’s startups are ready to lead the global innovation race 💥 Yesterday, Harald joined a panel at ETH Zürich to discuss bridging the shrinking gap between European and US startups. Here are three takeaways that reaffirm our conviction in the outstanding quality of European tech: 𝗢𝘄𝗻 𝗼𝘂𝗿 𝘀𝘂𝗽𝗲𝗿𝗽𝗼𝘄𝗲𝗿𝘀: While Silicon Valley has speed, Europe has deep technical depth, world-class research, and a values-driven approach to business. Europe's advantage? We’re poised to lead in complex, high-barrier sectors at the connection of software and science, including climate tech and biotech. 𝗔𝗺𝗽𝗹𝗶𝗳𝘆 𝗯𝗼𝗹𝗱𝗻𝗲𝘀𝘀: American startups scale quickly because they don’t wait for perfect. Europe’s founders must adopt an equally fearless mindset - test fast, fail fast, iterate faster. As VCs, we need to back that ambition and capital should flow as freely as the ideas it fuels. 𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗺𝗮𝗰𝗿𝗼 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁: The 2024 US election underscored a global shift: every region is doubling down on its own progress. For Europe, this is a call to action. We must stand on our own feet by leveraging our unique strengths. The world isn’t waiting, and neither should we. 🚀 #empoweringGameChangers - At redalpine, we’ve proudly backed European tech since 2006. As we look to the next chapter of innovation, let's build big, dream bigger, and lead with both profit and purpose.

What lies ahead beyond the AI hype? Join us at the upcoming FRANKFURT DIGITAL FINANCE 2025 conference, where Sebastian will talk dive into this topic on an expert panel titled "The Great Beyond – AI Opportunities After the Hype". 🗓️ Wednesday, February 12 🕑 2:00pm This session will explore the future of AI and the opportunities that lie beyond the initial hype wave. Sebastian will be joined by Dr. Sina Wulfmeyer (Unique) Stephan A. Paxmann (LBBW), and Christian Weil (Bethmann Bank), with Sascha Beck (GFT Technologies) moderating the panel. 🚀 #empoweringGameChangers – We look forward to taking part in the conference and connecting with the European digital finance community! If you’re there too, please reach out to Sebastian. #FrankfurtDigitalFinance #AI #VentureCapital #redalpine #fintech

Mira is a true powerhouse. Whether she’s delivering sharp insights into investments, championing our portfolio companies, or uncovering Berlin’s hottest new restaurants for team dinners, she brings it all to the table. Since joining redalpine three years ago as our first Berlin-based hire, Mira has been instrumental in establishing our local presence. Today, we’re delighted to announce her well-deserved promotion to Principal and Managing Director Germany! 🚀 #empoweringGameChangers - Throughout her tenure, Mira has led investments in companies like 011h, Apaleo, and Lakera, spearheaded our portfolio success program, and managed our Visiting Analysts, mentoring 15 talented interns along the way. Beyond her professional contributions, Mira is a cornerstone of our team and culture. She brings an infectious energy to everything from our team meetings to weekly spin classes 🚴 💥 Congratulations, Mira, on this incredible milestone - we can’t wait to see the continued impact you’ll have in shaping redalpine’s future!

9fin is revolutionizing debt capital markets – and doing it fast! 🚀 We’re delighted to share that 9fin has been recognized as one of Britain’s Top 20 Fastest-Growing Tech Companies in The Times Tech 100! Since 2016, 9fin has transformed the debt capital market with its AI powered data and analytics platform. Today, it’s the go-to platform for over 200 global investment banks, law firms, and asset managers. This latest recognition is a testament to the hard work, innovation, and dedication of the entire 9fin team - big congratulations to founders Steven Hunter and Huss E. on this incredible milestone! 🎉  🚀#empoweringGameChangers - We’re proud to accompany the 9fin leadership team from the very beginning, with Harald and Marc providing hands-on support to help drive even greater success in 2025! Read more here: https://lnkd.in/eutHt7Je #VentureCapital #DebtCapitalMarkets #fintech #redalpinePortfolio #Startups

💪 The second milestone this week in our portfolio’s fight against cancer: Genialis has partnered with Tempus AI to tackle the critical data gap in cancer treatment. Without reliable biomarkers, clinicians struggle to predict how cancer patients will respond to therapies. Genialis Supermodel, built on ~1 million globally diverse RNA-sequencing samples, is taking on this challenge, connecting software and science to set a new standard for biomarker accuracy. By transforming RNA data into actionable insights, it accelerates drug development and allows clinicians to make more informed and personalized treatment decisions. 🚀 #empoweringGameChangers - As seed investors since 2017, Michael and Luca continue to support the Genialis leadership team Miha Stajdohar, Tjaša Krisper - Kutin, Rafael Rosengarten, and Luka Ausec in their aim to drive better outcomes for patients worldwide. 👉 Learn more here: https://lnkd.in/dvkjRFPh

👏 Congrats are in order for Araris Biotech AG! They recently announced a major research collaboration and option to license agreement with Chugai Pharmaceutical Co., Ltd. in a landmark deal totally up to $780M plus royalties! This collaboration combines Chugai’s antibodies with Araris’ innovative linker-conjugation platform, unlocking the potential for groundbreaking cancer treatments. 🚀 #empoweringGameChangers - We are proud to be the first-check investor in Araris, with Michael serving on the board from the very beginning. From the first pitch to this major achievement, we’ve been committed to supporting Dragan Grabulovski, Isabella Attinger-Toller, Philipp Spycher, and the entire Araris team in their mission. The latest collaboration underscores Araris' world-leading, readily applicable ADC engineering platform at the connection of software and science, along with its transformative potential in the fight against cancer. #OncologyBreakthroughs #ADCTechnology #BiotechInnovation